CVE-2012-3521

Public Exploit

Description

Multiple directory traversal vulnerabilities in the cssgen contrib module in GeSHi before 1.0.8.11 allow remote attackers to read arbitrary files via a .. (dot dot) in the (1) geshi-path or (2) geshi-lang-path parameter.

Category

5.0
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.87% Top 30%
Vendor Advisory fedoraproject.org Vendor Advisory fedoraproject.org Vendor Advisory fedoraproject.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://sourceforge.net/p/geshi/code/2507/ patch exploit
http://lists.fedoraproject.org/pipermail/package-announce/2013-May/105317.html vendor advisory
http://lists.fedoraproject.org/pipermail/package-announce/2013-May/105273.html vendor advisory
https://bugs.debian.org/cgi-bin/bugreport.cgi?bug=685324
http://lists.fedoraproject.org/pipermail/package-announce/2013-May/105247.html vendor advisory
http://www.openwall.com/lists/oss-security/2012/08/21/11 mailing list

Frequently Asked Questions

What is the severity of CVE-2012-3521?
CVE-2012-3521 has been scored as a medium severity vulnerability.
How to fix CVE-2012-3521?
To fix CVE-2012-3521, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2012-3521 being actively exploited in the wild?
It is possible that CVE-2012-3521 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.